scispace - formally typeset
L

Lesa L. Aylward

Researcher at University of Queensland

Publications -  153
Citations -  5372

Lesa L. Aylward is an academic researcher from University of Queensland. The author has contributed to research in topics: Population & Biomonitoring. The author has an hindex of 38, co-authored 147 publications receiving 4530 citations. Previous affiliations of Lesa L. Aylward include Massachusetts Institute of Technology & Utrecht University.

Papers
More filters
Journal ArticleDOI

Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective

TL;DR: Issues inherent in converting existing health screening benchmarks based on intake doses to screening levels for evaluating biomonitoring data are discussed, and methods and approaches that can be used to derive such screening levels are presented for a range of chemicals and biological media.
Journal ArticleDOI

Age as a determinant of phosphate flame retardant exposure of the Australian population and identification of novel urinary PFR metabolites

TL;DR: Significantly greater levels of BDCIPP and DPHP were found in children's urine compared with adults, suggesting higher exposure to PFRs in young children and BCIPHIPP was identified for inclusion in future PFR biomonitoring studies.
Journal ArticleDOI

Human biomonitoring assessment values: Approaches and data requirements

TL;DR: Efforts to date have resulted in the publication of HBM assessment values for more than 80 chemicals, and now provide tools that can be used for the evaluation of H BM data across chemicals and populations.
Journal ArticleDOI

Dioxin risks in perspective: past, present, and future

TL;DR: There is a several-fold reduction in exposures and body burdens in the general population over the three decades from 1970 to 2000, and further efforts to reduce exposures through attempts to control emissions or food levels should be carefully evaluated to understand the likely efficacy of the efforts and the relative costs and benefits.